James Birkhead is the Director of Research & Development at Vericel Corporation, where they lead innovative efforts in cell biology and regenerative medicine. With a background as a senior scientist, James has extensive experience in technology transfer, clinical manufacturing, and process development, having previously held significant roles at companies such as Reprogenesis, TKT, Boston Scientific, and Shire. They have a proven track record of managing successful projects in cGMP environments and developing novel therapies through rigorous scientific evaluation. James is currently pursuing a Bachelor of Arts in Biological Science from the University of Delaware.
This person is not in the org chart
This person is not in any teams
This person is not in any offices